104 related articles for article (PubMed ID: 23184615)
1. Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity.
Kunne C; Acco A; Hohenester S; Duijst S; de Waart DR; Zamanbin A; Oude Elferink RP
Hepatology; 2013 Apr; 57(4):1509-17. PubMed ID: 23184615
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Kunne C; de Graaff M; Duijst S; de Waart DR; Oude Elferink RP; Paulusma CC
Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656
[TBL] [Abstract][Full Text] [Related]
3. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
[TBL] [Abstract][Full Text] [Related]
4. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion.
Pawlikowska L; Groen A; Eppens EF; Kunne C; Ottenhoff R; Looije N; Knisely AS; Killeen NP; Bull LN; Elferink RP; Freimer NB
Hum Mol Genet; 2004 Apr; 13(8):881-92. PubMed ID: 14976163
[TBL] [Abstract][Full Text] [Related]
5. Hepatic overexpression of caveolins increases bile salt secretion in mice.
Moreno M; Molina H; Amigo L; Zanlungo S; Arrese M; Rigotti A; Miquel JF
Hepatology; 2003 Dec; 38(6):1477-88. PubMed ID: 14647059
[TBL] [Abstract][Full Text] [Related]
6. Intestinal bile salt absorption in Atp8b1 deficient mice.
Groen A; Kunne C; Paulusma CC; Kramer W; Agellon LB; Bull LN; Oude Elferink RP
J Hepatol; 2007 Jul; 47(1):114-22. PubMed ID: 17448567
[TBL] [Abstract][Full Text] [Related]
7. Bile salt independent flow during bile salt-induced choleresis and cholestasis in the rat: role of biliary thiol secretion.
Bouchard G; Tuchweber B; Yousef IM
Liver; 2000 Feb; 20(1):27-37. PubMed ID: 10726958
[TBL] [Abstract][Full Text] [Related]
8. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
9. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
[TBL] [Abstract][Full Text] [Related]
10. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.
Oude Elferink RP; Ottenhoff R; van Wijland M; Smit JJ; Schinkel AH; Groen AK
J Clin Invest; 1995 Jan; 95(1):31-8. PubMed ID: 7814632
[TBL] [Abstract][Full Text] [Related]
11. Effects of taurodihydrofusidate, a bile salt analogue, on bile formation and biliary lipid secretion in the rhesus monkey.
Beaudoin M; Carey MC; Small DM
J Clin Invest; 1975 Dec; 56(6):1431-41. PubMed ID: 811689
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
[TBL] [Abstract][Full Text] [Related]
13. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic transport of bile salt. Effect of protein synthesis inhibition on excretion of bile salts and their binding to liver surface membrane fractions.
Gonzalez MC; Sutherland E; Simon FR
J Clin Invest; 1979 Apr; 63(4):684-94. PubMed ID: 438330
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.
Bodewes FA; Wouthuyzen-Bakker M; Bijvelds MJ; Havinga R; de Jonge HR; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1035-42. PubMed ID: 22301109
[TBL] [Abstract][Full Text] [Related]
17. Functional and ultrastructural features of ethanol/bile salts interaction in the isolated perfused rat liver.
Alvaro D; Benedetti A; Gigliozzi A; Bini A; Della Guardia P; La Rosa T; Jezequel AM; Capocaccia L
Hepatology; 1995 Apr; 21(4):1120-9. PubMed ID: 7705787
[TBL] [Abstract][Full Text] [Related]
18. Effects of obesity and caloric intake on biliary lipid metabolism in man.
Bennion LJ; Grundy SM
J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the hepatic CYP reductase null mouse model and its potential application in drug discovery.
Boggs JW; Hop CE; McNamara E; Deng Y; Messick K; West K; Choo EF
Mol Pharm; 2014 Mar; 11(3):1062-8. PubMed ID: 24450768
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of 17alpha-ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat.
Koopen NR; Post SM; Wolters H; Havinga R; Stellaard F; Boverhof R; Kuipers F; Princen HM
J Lipid Res; 1999 Jan; 40(1):100-8. PubMed ID: 9869655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
